The FDA regulation 21 CFR Part 11 is a foundational component of modern clinical trial data management. What is its primary purpose?
-
A
To define the specific technical specifications for all Electronic Data Capture (EDC) software used in clinical trials.
-
B
To establish the standards under which electronic records and electronic signatures are considered trustworthy, reliable, and equivalent to paper records.
-
C
To mandate the use of electronic systems for all new clinical trials to improve efficiency over paper-based methods.
-
D
To outline the security requirements for protecting patient privacy in electronic health records (EHRs), superseding HIPAA.